Skip to main content
. 2023 Nov 10;14:1280873. doi: 10.3389/fendo.2023.1280873

Table 2.

Association between Klotho and hyperlipidemia among US adults in NHANES 2007–2016.

Klotho (pg/mL) Crude model Model 1 Model 2
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Per SD increase 0.87 (0.82, 0.93) < 0.001 0.90 (0.85, 0.95) < 0.001 0.91 (0.86, 0.97) 0.005
Quartiles
 Q1 (≤ 654.33) Reference Reference Reference
 Q2 (654.33 – 801.40) 1.00 (0.82, 1.22) 0.971 1.03 (0.84, 1.25) 0.787 1.05 (0.86, 1.28) 0.614
 Q3 (801.40 – 990.93) 0.80 (0.66, 0.96) 0.019 0.82 (0.68, 1.00) 0.049 0.84 (0.69, 1.02) 0.083
 Q4 (> 993.93) 0.65 (0.53, 0.80) < 0.001 0.70 (0.57, 0.86) 0.001 0.72 (0.58, 0.90) 0.004
p for trend < 0.001 < 0.001 < 0.001
Categories
 Q1–Q3 (≤ 993.93) Reference Reference Reference
 Q4 (> 993.93) 0.70 (0.60, 0.82) < 0.001 0.74 (0.63, 0.87) 0.001 0.75 (0.63, 0.89) 0.002

Crude model: no cofounder.

Model 1: adjusted for age, gender, etc.

Model 2: adjusted for age, gender, race, education, alcohol intake, smoking status, body mass index, the family of poverty ratio, hypertension, diabetes, and CVD.

OR, odds ratio; CI, confidence interval.